ControlCam Offers Businesses In America's Smallest State A Big Opportunity

Businesses In Rhode Island Can Win A Free Parcel Centric Aerial Survey Of Their Office, Plant Or Facility

2012-07-17

JACKSONVILLE, FL, July 17, 2012 (Press-News.org) ControlCam announced today that by the end of July, 2012 it will complete the fly over of the entire State of Rhode Island, capturing 360 degree aerial images of every parcel of land in the Ocean State. "We are covering every inch of Rhode Island's 1,214 square miles," said Billy Meadow, CEO of ControlCam.

ControlCam aerial images allow businesses to see their operations from the air. This provides information not available from ground imaging. This allows any business to see how customers access their facilities plus a cleaner, more comprehensive view of important areas like parking, drainage and environmental spaces. In other words it's the complete picture. These images often can provide important information needed to make better business decisions.

The ControlCam contest will direct Rhode Island businesses to a Facebook fan page (www.facebook.com/controlcam) where they will be asked to enter basic contact information by August 15, 2012. A random drawing will be performed to select a winner. ControlCam will announce the winner online via Facebook and the ControlCam website (www.controlcam.com) on August 31, 2012. The winner will receive a parcel centric survey of their office, plant or facility.

ControlCam LLC, a Jacksonville, Florida based company has a Rhode Island connection. Bay Capital Advisors a Providence, Rhode Island based investment banking company has been an investor in ControlCam since 2011. ControlCam operates a squadron of Cessna aircraft equipped with a proprietary image capture system capable of capturing several dozen high resolution photos of every parcel from a variety of angles. The patented process automatically stabilizes our camera orientations so we can accurately encode and align photos to the target Latitude and Longitude. ControlCam's Control Central technology platform also enables businesses to access parcel centric imagery and helps them make better decisions around plants, business access, and expansion by seeing an up to date aerial view.

For more information on ControlCam's technology contact Billy Meadow 904 758-2601 billymeadow@controlcam.com

About ControlCam LLC

ControlCam is a developer of imaging technologies. ControlCam provides its patented image capture, processing, hosting and delivery products and services to image distribution partners via our API and directly to business users through our cloud based technology. The markets for ControlCam parcel centric based visualizations include real estate sales, appraisal, mortgage lending, insurance, GIS and governments agencies or anyone with a need high quality aerial imagery. To find out more about how ControlCam imagery can meet your needs, visit ControlCam's web site at: www.controlcam.com. To request additional information Billy Meadow at 904-758-2601; or email billymeadow@controlcam.com

ELSE PRESS RELEASES FROM THIS DATE:

Differences between human twins at birth highlight importance of intrauterine environment

2012-07-16

July 16, 2012 – Your genes determine much about you, but environment can have a strong influence on your genes even before birth, with consequences that can last a lifetime. In a study published online in Genome Research (www.genome.org), researchers have for the first time shown that the environment experienced in the womb defines the newborn epigenetic profile, the chemical modifications to DNA we are born with, that could have implications for disease risk later in life. Epigenetic tagging of genes by a chemical modification called DNA methylation is known to affect ...

TV habits predict kids' waist size and sporting ability

2012-07-16

Each hour of TV watched by a two- to four-year- old contributes to his or her waist circumference by the end of grade 4 and his or her ability to perform in sports, according to a world-first study undertaken by researchers at the University of Montreal and its affiliated Saint-Justine Mother and Child University Hospital. The findings were published today by lead author Dr. Caroline Fitzpatrick and senior author Dr. Linda Pagani in BioMed Central's open access journal the International Journal of Behavioral Nutrition and Physical Activity. "We already knew that there ...

Elegant delivery

2012-07-16

Cancers are notorious for secreting chemicals that confuse the immune system and thwarting biological defenses. To counter that effect, some cancer treatments try to neutralize the cancer's chemical arsenal and boost a patient's immune response--though attempts to do both at the same time are rarely successful. Now, researchers have developed a novel system to simultaneously deliver a sustained dose of both an immune-system booster and a chemical to counter the cancer's secretions, resulting in a powerful therapy that, in mice, delayed tumor growth, sent tumors into ...

New gene mutations linked to ALS and nerve cell growth dysfunction

2012-07-16

Researchers have linked newly discovered gene mutations to some cases of the progressive fatal neurological disease amyotrophic lateral sclerosis – ALS, also known as Lou Gehrig's disease. Shedding light on how ALS destroys the cells and leads to paralysis, the researchers found that mutations in this gene affect the structure and growth of nerve cells. ALS attacks motor neurons, the nerve cells responsible for controlling muscles. People with ALS experience such early symptoms as limb weakness or swallowing difficulties. In most people, the disease leads to death three ...

UMMS researchers isolate gene mutations in patients with inherited amyotrophic lateral sclerosis

2012-07-16

WORCESTER, Mass. — A new genetic mutation that causes familial amyotrophic lateral sclerosis (ALS), a fatal neurological disorder also known as Lou Gehrig's Disease, has been identified by a team of scientists led by researchers at the University of Massachusetts Medical School (UMMS). Mutations to the profilin (PFN1) gene, which is essential to the growth and development of nerve cell axons, is estimated to account for one to two percent of inherited ALS cases. The finding, described today in the online edition of Nature, points to defects in a neuron's cytoskeleton structure ...

Unique properties of graphene lead to a new paradigm for low-power telecommunications

2012-07-16

New research by Columbia Engineering demonstrates remarkable optical nonlinear behavior of graphene that may lead to broad applications in optical interconnects and low-power photonic integrated circuits. With the placement of a sheet of graphene just one-carbon-atom-thick, the researchers transformed the originally passive device into an active one that generated microwave photonic signals and performed parametric wavelength conversion at telecommunication wavelengths. "We have been able to demonstrate and explain the strong nonlinear response from graphene, which is ...

Could a larger waistline be a result of too much TV as a child?

2012-07-16

As a youngster, remember your mother warning you that watching too much television would give you square eyes? That might not be true, but a new study, published today in BioMed Central's open access journal International Journal of Behavioral Nutrition and Physical Activity, has found that the more hours young children spend watching TV, the worse their muscular fitness and the larger their waist size as they approach their teens, with possible consequences for adult health. The American Academy of Pediatrics recommends that children under the age of two should not exceed ...

La Jolla institute identifies critical cell in fighting E. coli infection

2012-07-16

SAN DIEGO – (July 15, 2012) – Despite ongoing public health efforts, E. coli outbreaks continue to infiltrate the food supply, annually causing significant sickness and death throughout the world. But the research community is gaining ground. In a major finding, published today in the scientific journal Nature, researchers from the La Jolla Institute for Allergy & Immunology have discovered a molecule's previously unknown role in fighting off E. coli and other bacterial infections, a discovery that could lead to new ways to protect people from these dangerous microorganisms. "We've ...

Study reveals optimal interval for stomach cancer screening

2012-07-16

A new study has determined how often people should get screened for gastric or stomach cancer in high-risk regions of the world. Published early online in CANCER, a peer-reviewed journal of the American Cancer Society, the findings could help reduce deaths from gastric cancer, which is the second most common cause of cancer-related mortality. Although the incidence of gastric cancer has decreased substantially in the western part of the world, the disease is still common in areas such as Eastern Asia, including Korea, Japan, and China. Gastric cancer patients' prognosis ...

Mayo Clinic creates tool to track real-time chemical changes in brain

2012-07-16

ROCHESTER, Minn. -- Mayo Clinic researchers have found a novel way to monitor real-time chemical changes in the brains of patients undergoing deep brain stimulation (DBS). The groundbreaking insight will help physicians more effectively use DBS to treat brain disorders such as Parkinson's disease, depression and Tourette syndrome. The findings are published in the journal Mayo Clinic Proceedings. Journalists: For multimedia resources including video of a tremor patient undergoing DBS, visit the Mayo Clinic News Network. Researchers hope to use the discovery to create ...

LAST 30 PRESS RELEASES:

University of Cincinnati experts present research at annual hematology event

ASH 2025: Antibody therapy eradicates traces of multiple myeloma in preliminary trial

ASH 2025: AI uncovers how DNA architecture failures trigger blood cancer

ASH 2025: New study shows that patients can safely receive stem cell transplants from mismatched, unrelated donors

Protective regimen allows successful stem cell transplant even without close genetic match between donor and recipient

Continuous and fixed-duration treatments result in similar outcomes for CLL

Measurable residual disease shows strong potential as an early indicator of survival in patients with acute myeloid leukemia

Chemotherapy and radiation are comparable as pre-transplant conditioning for patients with b-acute lymphoblastic leukemia who have no measurable residual disease